Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)

NCT00188136

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: University hospital Carl Gustav Carus Dresden, Germany

View Trial Details

Completed

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

NCT01397799

Conditions: Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

Weill Cornell Medical College New York, United States

Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia

NCT00459212

Conditions: Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +40 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00062075

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +15 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Vanderbilt University Nashville, Tennessee, United States

View Trial Details

Completed

Treosulfan-based Conditioning for Transplantation in AML/MDS

NCT00491634

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Chaim Sheba Medical Center Tel Litwinsky, Israel

View Trial Details

Completed

PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML

NCT00303290

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +12 more
Locations: The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib

NCT00802841

Conditions: Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +22 more
Locations: Novartis Investigative Site Caba, Buenos Aires, Argentina

Novartis Investigative Site Caba, Buenos Aires, Argentina

Novartis Investigative Site La Plata, Buenos Aires, Argentina

Novartis Investigative Site Rio Negro, Viedma, Argentina

View all 56 locations

View Trial Details

Completed

Non-interventional Study With Azacitidin (Vidaza®)

NCT01192945

Conditions: AML, Bone Marrow Diseases, CMMOL, +15 more
Locations: iOMEDICO AG Freiburg im Breisgau, Baden-Wurttemberg, Germany

View Trial Details

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

NCT00161187

Conditions: Adenocarcinoma, Adnexal Diseases, Blast Crisis, +151 more
Locations: Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Completed

Oral Clofarabine Study in Patients With Myelodysplastic Syndrome

NCT00299156

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions